ICAM1 and B-cell non-Hodgkin lymphoma: We repeated NK-92 competitive co-culture experiments after disruption of DCAF15, PTPN2, STAT1 and ICAM1 in Daudi cells, a B2M-deficient B-cell lymphoma line (Figure 3D, Figure 3—figure supplement 1D–F).